The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies
about
Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trialSuppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5.Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats.Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early lifeCancer Stem Cells in Moderately Differentiated Lip Squamous Cell Carcinoma Express Components of the Renin-Angiotensin SystemUse of renin-angiotensin inhibitors in people with renal artery stenosisPrehypertension: Underlying pathology and therapeutic options.Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus.Targeting stem cell niches and trafficking for cardiovascular therapyACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysmIndications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular riskBiology of intracranial aneurysms: role of inflammation.The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis.Cardiovascular morbidity and mortality and renal artery stenosis.Telmisartan: a different angiotensin II receptor blocker protecting a different population?Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction?Atherosclerosis in chronic kidney disease: the role of macrophagesLocal bone marrow Renin-Angiotensin system and atherosclerosis.LOX-1, OxLDL, and atherosclerosisTreatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials.Inhibition of Angiotensin Converting Enzyme, Angiotensin II Receptor Blocking, and Blood Pressure Lowering Bioactivity across Plant Families.Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.Valsartan blocked alcohol-induced, Toll-like receptor 2 signaling-mediated inflammation in human vascular endothelial cells.Effect of candesartan on the expression of sclera-choroidal intercellular adhesion molecule-1 in hypercholesterolemic models.A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.Inflammatory cardiovascular risk biomarkers: update on novelties and limitations.Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy.The angiotensin-converting enzyme inhibitor captopril rescues mice from endotoxin-induced lethal hepatitis.Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy.Treating Hypertension to Prevent Cognitive Decline and Dementia: Re-Opening the Debate.A novel role for calpain in the endothelial dysfunction induced by activation of angiotensin II type 1 receptor signaling
P2860
Q28484460-069187C1-4F4C-4A9E-80E7-C8A67A65B4A9Q31152104-F3DED217-D358-4C85-A3D6-9342648399C7Q33713970-AB7682CA-4F5D-47ED-BA5D-8743B774099DQ33735189-1D72DDFE-9476-4DA0-8FFD-00D2EA6BF5F9Q33766069-11EA901E-033C-4E1A-8985-3ADD319D1CC9Q33835760-5F6D741F-BE68-42FA-9073-73A4BDD40E6EQ34179007-FD61AC05-DD8A-4165-A0AA-E4101BA8BB4CQ34385696-ACFA9D8D-F47B-4933-A5CB-033AB0C419A4Q34475689-43CB56E5-89F9-46FF-BC21-336D5E142692Q34634364-5F70C73B-5F12-488E-939A-0FD261BF940DQ35539305-51114DCB-7C12-4F0E-9ABE-D0415CE40562Q36211346-4B855C09-1A97-4B6F-A7F6-B5CA462E468AQ36576745-AD2E0A22-75C1-4D20-834C-5B89211CE854Q37633683-97B87C06-CA9C-462E-A7C5-4DFEACBC0E59Q37690442-0F3AE11E-5638-4460-A22F-064572015F66Q37768188-7525A80A-7FDB-4966-B272-A56356FA4678Q37811885-2D0FE657-B696-4367-A805-0CA4F0A565BFQ37828412-414FE908-DB32-409C-AD13-53C57E6CC6C6Q38128283-338FC0CC-655F-4592-B861-CB4C306DDEF5Q38205416-690D9FAF-140D-45EB-A3C0-D78270083EA8Q38219179-FFE639E1-3B46-406C-8AE4-5861ACD07027Q38317550-A0779379-AFF4-41CB-90FC-513870ADC956Q38944982-AD540C1E-CA5E-4622-AD23-77E5D8E66950Q41870370-3072C71F-56D2-4CFD-B33F-91288D016904Q42109762-18A4404A-F750-49AD-9B11-4A08EDFFD8CDQ42830261-D1D2762E-1897-48C9-AAFD-A9AC546DCE1CQ45769086-75ED08FA-C4C4-4942-9BAF-551256F9059EQ51094217-C13FBDBC-FDEC-4DDB-86C7-181857D1EC9EQ53011547-1A3352D6-3789-45EA-87F1-CB9C868DDC0DQ53842206-1ABB9F0F-9196-4102-AB1D-E3C6DE8EA501Q57724014-69C367CC-FAF3-4850-B525-1E43A41F42F9
P2860
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The renin-angiotensin system m ...... research and clinical studies
@en
The renin-angiotensin system m ...... research and clinical studies.
@nl
type
label
The renin-angiotensin system m ...... research and clinical studies
@en
The renin-angiotensin system m ...... research and clinical studies.
@nl
prefLabel
The renin-angiotensin system m ...... research and clinical studies
@en
The renin-angiotensin system m ...... research and clinical studies.
@nl
P2860
P356
P1476
The renin-angiotensin system m ...... research and clinical studies
@en
P2093
Aldo Pende
François Mach
P2860
P304
P356
10.1155/2009/752406
P5008
P577
2009-04-14T00:00:00Z